Optimization of light source parameters in the photodynamic therapy of heterogeneous prostate

The three-dimensional (3D) heterogeneous distributions of optical properties in a patient prostate can now be measured in vivo. Such data can be used to obtain a more accurate light-fluence kernel. (For specified sources and points, the kernel gives the fluence delivered to a point by a source of unit strength.) In turn, the kernel can be used to solve the inverse problem that determines the source strengths needed to deliver a prescribed photodynamic therapy (PDT) dose (or light-fluence) distribution within the prostate (assuming uniform drug concentration). We have developed and tested computational procedures to use the new heterogeneous data to optimize delivered light-fluence. New problems arise, however, in quickly obtaining an accurate kernel following the insertion of interstitial light sources and data acquisition. (1) The light-fluence kernel must be calculated in 3D and separately for each light source, which increases kernel size. (2) An accurate kernel for light scattering in a heterogeneous medium requires ray tracing and volume partitioning, thus significant calculation time. To address these problems, two different kernels were examined and compared for speed of creation and accuracy of dose. Kernels derived more quickly involve simpler algorithms. Our goal is to achieve optimal dose planning with patient-specific heterogeneous optical data applied through accurate kernels, all within clinical times. The optimization process is restricted to accepting the given (interstitially inserted) sources, and determining the best source strengths with which to obtain a prescribed dose. The Cimmino feasibility algorithm is used for this purpose. The dose distribution and source weights obtained for each kernel are analyzed. In clinical use, optimization will also be performed prior to source insertion to obtain initial source positions, source lengths and source weights, but with the assumption of homogeneous optical properties. For this reason, we compare the results from heterogeneous optical data with those obtained from average homogeneous optical properties. The optimized treatment plans are also compared with the reference clinical plan, defined as the plan with sources of equal strength, distributed regularly in space, which delivers a mean value of prescribed fluence at detector locations within the treatment region. The study suggests that comprehensive optimization of source parameters (i.e. strengths, lengths and locations) is feasible, thus allowing acceptable dose coverage in a heterogeneous prostate PDT within the time constraints of the PDT procedure.

[1]  Yair Censor,et al.  Component averaging: An efficient iterative parallel algorithm for large and sparse unstructured problems , 2001, Parallel Comput..

[2]  S B Malkowicz,et al.  Preliminary results of interstitial motexafin lutetium‐mediated PDT for prostate cancer , 2006, Lasers in surgery and medicine.

[3]  Y. Censor,et al.  On the use of Cimmino's simultaneous projections method for computing a solution of the inverse problem in radiation therapy treatment planning , 1988 .

[4]  B. Wilson,et al.  Changes in in vivo optical properties and light distributions in normal canine prostate during photodynamic therapy. , 1997, Radiation research.

[5]  M. Altschuler,et al.  Optimized interstitial PDT prostate treatment planning with the Cimmino feasibility algorithm. , 2005, Medical physics.

[6]  Jarod C Finlay,et al.  Determination of the distribution of light, optical properties, drug concentration, and tissue oxygenation in-vivo in human prostate during motexafin lutetium-mediated photodynamic therapy. , 2005, Journal of photochemistry and photobiology. B, Biology.

[7]  Timothy C. Zhu,et al.  Optical Properties of Human Prostate at 732 nm Measured In Vivo During Motexafin Lutetium–mediated Photodynamic Therapy¶ , 2005 .

[8]  Timothy C. Zhu,et al.  Phase I trial of motexafin-lutetium-mediated interstitial photodynamic therapy in patients with locally recurrent prostate cancer , 2004, SPIE BiOS.

[9]  Timothy C Zhu,et al.  Updated results of a phase I trial of motexafin lutetium-mediated interstitial photodynamic therapy in patients with locally recurrent prostate cancer. , 2006, Journal of environmental pathology, toxicology and oncology : official organ of the International Society for Environmental Toxicology and Cancer.

[10]  Shi-Chung Chang,et al.  Interstitial photodynamic therapy in the canine prostate with disulfonated aluminum phthalocyanine and 5‐aminolevulinic acid‐induced protoporphyrin IX , 1997, The Prostate.

[11]  Timothy C Zhu,et al.  In vivo Optical Properties of Normal Canine Prostate at 732 nm Using Motexafin Lutetium–mediated Photodynamic Therapy¶ , 2003, Photochemistry and photobiology.

[12]  Timothy C Zhu,et al.  Modeling light fluence rate distribution in optically heterogeneous prostate photodynamic therapy using a kernel method , 2007, SPIE BiOS.

[13]  F. Hetzel,et al.  Interstitial photodynamic therapy in the canine prostate. , 1997, British journal of urology.

[14]  Michele Benzi,et al.  GIANFRANCO CIMMINO'S CONTRIBUTIONS TO NUMERICAL MATHEMATICS , 2004 .

[15]  Timothy C Zhu,et al.  Determination of in vivo light fluence distribution in a heterogeneous prostate during photodynamic therapy , 2008, Physics in Medicine and Biology.

[16]  Jarod C Finlay,et al.  Study of light fluence rate distribution in photodynamic therapy using finite-element method , 2006, SPIE BiOS.

[17]  M. Schweiger,et al.  The finite element method for the propagation of light in scattering media: boundary and source conditions. , 1995, Medical physics.

[18]  A. D'Amico,et al.  Role of interstitial radiotherapy in the management of clinically organ-confined prostate cancer: the jury is still out. , 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[19]  S. Jacques,et al.  Light Distributions from Point, Line and Plane Sources for Photochemical Reactions and Fluorescence in Turbid Biological Tissues , 1998, Photochemistry and photobiology.

[20]  Mamoru Tamura,et al.  Expression of optical diffusion coefficient in high-absorption turbid media , 1997 .

[21]  Shi-Chung Chang,et al.  Interstitial and transurethral photodynamic therapy of the canine prostate using meso‐tetra‐(m‐hydroxyphenyl) chlorin , 1996, International journal of cancer.

[22]  M D Altschuler,et al.  Semi-automated radiotherapy treatment planning with a mathematical model to satisfy treatment goals. , 1989, International journal of radiation oncology, biology, physics.

[23]  M Saunders,et al.  Photodynamic therapy in the canine prostate using motexafin lutetium. , 2001, Clinical cancer research : an official journal of the American Association for Cancer Research.

[24]  A. Pierro,et al.  A simultaneous projections method for linear inequalities , 1985 .